FI82036B - Foerfarande foer framstaellning av terapeutiskt anvaendbara n-indolyletylsulfonsyraamider. - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara n-indolyletylsulfonsyraamider. Download PDFInfo
- Publication number
- FI82036B FI82036B FI861683A FI861683A FI82036B FI 82036 B FI82036 B FI 82036B FI 861683 A FI861683 A FI 861683A FI 861683 A FI861683 A FI 861683A FI 82036 B FI82036 B FI 82036B
- Authority
- FI
- Finland
- Prior art keywords
- alkyl
- compounds
- cyano
- optionally
- hydrogen
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C07D209/16—Tryptamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Claims (4)
1. Förfarande för framställning av terapeutiskt användbara N-indolyletylsulfonsyraamider med formeln (la) 5 och salter därav, ^ (ch2) 2-n-so2-r3 10 ch2 CHR5 COOH 15 där R1 betecknar väte, fluor, klor, brom, trifluormetyl, grup-pen -O-R9, där R9 betecknar väte, Cj-C4-alkyl, fenyl eller bensyl, eller C1-C4-alkyl, som eventuellt substituerats med fluor, klor och/eller cyan,
20 R3 betecknar C^-C^-alkyl, fenyl eller naftyl, vilka eventuellt upp tili trefaldigt substituerats med fluor, klor, brom, cyan, hydroxi, trifluormetyl, karboxivinyl, C^-C^-alkyl, Cj-C4-alkoxi, C^-C^-metoxi- eller -etoxikarbonylal-kyl, fenyl, fenoxi, amino, dimetylamino och/eller acetyl- 25 amino, eller pyridyl, tienyl, piperidinyl eller kinolyl, bensotiadiazolyl eller indolonyl, vilka eventuellt substi tuerats med C^-C^-alkyl, R4 betecknar väte, metyl, etyl, hydroximetyl, hydroxietyl, metylkarbonyl, cyan eller fenyl, och
30 R5 betecknar väte eller Cj-C^-alkyl, kännetecknat därav, att indolylalkylaminer med formeln 35 r1—L il il h H III) 28 8 2 0 3 6 där R1’ betecknar samma som R1 ovan, förutom att R9 inte är vä-te, och R4 betecknar sanuna som ovan, omsätts med sulfonsyrahalogenider med formeln 5 R3-S02-Y (III) där R3 betecknar samma som ovan och Y betecknar halogen, i närvaro av ett inert lösningsmedel, eventuellt i närvaro 10 av en bas; därefter alkyleras med en olefinisk förening med formeln CH2-C-X' (IV) R5 15 där X’ betecknar Cj-CB-alkoxikarbonyl, cyan eller karbon-amido och R5 betecknar samma som ovan, i närvaro av ett inert lösningsmedel, eventuellt i närvaro av en bas, varefter, ifall framställs föreningar, vilka i 4-, 20 5-, 6- eller 7-ställning substituerats med hydroxi, hydre- ras motsvarande bensyloxiföreningar i närvaro av en kata-lysator i ett inert lösningsmedel, eventuellt i närvaro av en syra, och därefter hydrolyseras alkoxikarbonyl-, cyan-eller karbonamidogruppen X' tili en karboxylgrupp, 25 och därefter, ifall framställs salter, omsätts fö- reningarna med en motsvarande bas.
2. Förfarande enligt patentkravet 1, känne-t e c k n a t därav, att det utförs inom temper a tu rom r ä-det av -20°C...100°C. 30
3. Förfarande enligt patentkravet 1 eller 2, k ä n- netecknat därav, att vid framställning av hydr-oxiföreningar utförs hydreringen i närvaro av en ädelme-tallkatalysator.
4. Förfarande enligt patentkravet 1 eller 2, k ä n-35 netecknat därav, att vid framställning av kar- boxylföreningar utförs hydrolysen i närvaro av en aikaii-eller jordalkalimetallhydroxid eller -alkoholat.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3514696 | 1985-04-24 | ||
| DE19853514696 DE3514696A1 (de) | 1985-04-24 | 1985-04-24 | N-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| FI861683A0 FI861683A0 (fi) | 1986-04-22 |
| FI861683A FI861683A (fi) | 1986-10-25 |
| FI82036B true FI82036B (fi) | 1990-09-28 |
| FI82036C FI82036C (sv) | 1991-01-10 |
Family
ID=6268925
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI861683A FI82036C (sv) | 1985-04-24 | 1986-04-22 | Förfarande för framställning av terapeutiskt användbara N-indolyletyls ulfonsyraamider |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4774240A (sv) |
| EP (1) | EP0201735B1 (sv) |
| JP (1) | JPH0625104B2 (sv) |
| KR (1) | KR930011299B1 (sv) |
| CN (1) | CN1015054B (sv) |
| AT (1) | ATE56433T1 (sv) |
| AU (1) | AU590267B2 (sv) |
| CA (1) | CA1321585C (sv) |
| DE (2) | DE3514696A1 (sv) |
| DK (1) | DK187186A (sv) |
| ES (1) | ES8802381A1 (sv) |
| FI (1) | FI82036C (sv) |
| GR (1) | GR861058B (sv) |
| HU (1) | HU195483B (sv) |
| IL (1) | IL78557A0 (sv) |
| NO (1) | NO167283C (sv) |
| PT (1) | PT82442B (sv) |
| ZA (1) | ZA863028B (sv) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3613623A1 (de) * | 1986-04-23 | 1987-10-29 | Bayer Ag | N-dihydroindolylethyl-sulfonamide |
| GB8717374D0 (en) * | 1987-07-22 | 1987-08-26 | Smith Kline French Lab | Pharmaceutically active compounds |
| DE3840338A1 (de) * | 1988-11-30 | 1990-05-31 | Bayer Ag | Neue 2-halogensubstituierte n-indolylethyl-sulfonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
| US5153214A (en) * | 1989-06-28 | 1992-10-06 | Ciba-Geigy Corporation | Certain (arylsulfonamido- and imidazolyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity |
| US5025025A (en) * | 1989-06-28 | 1991-06-18 | Ciba-Geigy Corporation | (Arylsulfonamido- and pyridyl-)-substituted carboxylic acids and derivatives thereof and use for suppressing thromboxane activity |
| GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
| GB9008108D0 (en) * | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
| WO1991018897A1 (en) * | 1990-06-07 | 1991-12-12 | The Wellcome Foundation Limited | Therapeutic heterocyclic compounds |
| US5189054A (en) * | 1990-11-02 | 1993-02-23 | Merrell Dow Pharmaceuticals Inc. | 3-amidoindolyl derivatives and pharmaceutical compositions thereof |
| US7605156B2 (en) * | 2001-12-03 | 2009-10-20 | Wyeth | Methods for the use of inhibitors of cytosolic phospholipase A2 |
| DE60318188T2 (de) * | 2002-03-26 | 2008-12-11 | Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield | Glucocorticoid-mimetika, deren herstellung, pharmazeutische zusammensetzungen und verwendung |
| US7534897B2 (en) * | 2002-05-16 | 2009-05-19 | Shionogi & Co., Ltd. | Indole arylsulfonaimide compounds exhibiting PGD 2 receptor antagonism |
| EP1539141B1 (en) * | 2002-08-29 | 2010-07-14 | Boehringer Ingelheim Pharmaceuticals Inc. | 3-(sulfonamidoethyl)-indole derivatives for use as glucocorticoid mimetics in the treatment of inflammatory, allergic and proliferative diseases |
| UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| US7795272B2 (en) * | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| US7754755B2 (en) * | 2004-09-23 | 2010-07-13 | Bristol-Myers Squibb Company | Inhibitors of 15-lipoxygenase |
| BRPI0517263A (pt) * | 2004-10-29 | 2008-10-07 | Astrazeneca Ab | novos derivados de sulfonamida como moduladores do receptor de glicocorticóide para o tratamento de doenças inflamatórias |
| JP2008525525A (ja) * | 2004-12-27 | 2008-07-17 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | グルココルチコイドミメティクス、その製法、医薬組成物及び使用 |
| TW200829578A (en) | 2006-11-23 | 2008-07-16 | Astrazeneca Ab | Chemical compounds 537 |
| CA2671990A1 (en) * | 2006-12-06 | 2008-06-12 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| JO2754B1 (en) | 2006-12-21 | 2014-03-15 | استرازينكا ايه بي | Amylendazoleil derivatives for the treatment of glucocorticoid-mediated disorders |
| US7750027B2 (en) * | 2008-01-18 | 2010-07-06 | Oxagen Limited | Compounds having CRTH2 antagonist activity |
| UY31832A (es) | 2008-05-20 | 2010-01-05 | Astrazeneca Ab | Derivados de indazol sustituidos con fenilo y benzodioxinilo |
| AU2009256289A1 (en) * | 2008-06-06 | 2009-12-10 | Boehringer Ingelheim International Gmbh | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| GB201407820D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| GB201407807D0 (en) | 2014-05-02 | 2014-06-18 | Atopix Therapeutics Ltd | Polymorphic form |
| CN105399697A (zh) * | 2014-09-12 | 2016-03-16 | 苏州旺山旺水生物医药有限公司 | 一种氨基磺酰基类化合物、其制备方法及用途 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1332410C (en) * | 1984-06-26 | 1994-10-11 | Roger M. Freidinger | Benzodiazepine analogs |
-
1985
- 1985-04-24 DE DE19853514696 patent/DE3514696A1/de not_active Withdrawn
-
1986
- 1986-04-08 NO NO861366A patent/NO167283C/no unknown
- 1986-04-12 EP EP86105038A patent/EP0201735B1/de not_active Expired - Lifetime
- 1986-04-12 AT AT86105038T patent/ATE56433T1/de not_active IP Right Cessation
- 1986-04-12 DE DE8686105038T patent/DE3674059D1/de not_active Expired - Lifetime
- 1986-04-14 US US06/852,475 patent/US4774240A/en not_active Expired - Fee Related
- 1986-04-21 IL IL78557A patent/IL78557A0/xx not_active IP Right Cessation
- 1986-04-22 JP JP61091408A patent/JPH0625104B2/ja not_active Expired - Lifetime
- 1986-04-22 GR GR861058A patent/GR861058B/el unknown
- 1986-04-22 CA CA000507203A patent/CA1321585C/en not_active Expired - Fee Related
- 1986-04-22 CN CN86102761A patent/CN1015054B/zh not_active Expired
- 1986-04-22 FI FI861683A patent/FI82036C/sv not_active IP Right Cessation
- 1986-04-22 PT PT82442A patent/PT82442B/pt not_active IP Right Cessation
- 1986-04-23 KR KR1019860003115A patent/KR930011299B1/ko active IP Right Grant
- 1986-04-23 ZA ZA863028A patent/ZA863028B/xx unknown
- 1986-04-23 ES ES554285A patent/ES8802381A1/es not_active Expired
- 1986-04-23 HU HU861695A patent/HU195483B/hu not_active IP Right Cessation
- 1986-04-23 DK DK187186A patent/DK187186A/da not_active Application Discontinuation
- 1986-04-24 AU AU56726/86A patent/AU590267B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| HUT41385A (en) | 1987-04-28 |
| FI861683A (fi) | 1986-10-25 |
| DE3514696A1 (de) | 1986-11-06 |
| KR930011299B1 (ko) | 1993-11-29 |
| GR861058B (en) | 1986-08-19 |
| CA1321585C (en) | 1993-08-24 |
| ATE56433T1 (de) | 1990-09-15 |
| KR860008137A (ko) | 1986-11-12 |
| NO861366L (no) | 1986-10-27 |
| JPH0625104B2 (ja) | 1994-04-06 |
| ES8802381A1 (es) | 1988-05-16 |
| HU195483B (en) | 1988-05-30 |
| NO167283C (no) | 1991-10-23 |
| ZA863028B (en) | 1987-12-30 |
| FI861683A0 (fi) | 1986-04-22 |
| CN1015054B (zh) | 1991-12-11 |
| DE3674059D1 (de) | 1990-10-18 |
| JPS61249960A (ja) | 1986-11-07 |
| DK187186A (da) | 1986-10-25 |
| NO167283B (no) | 1991-07-15 |
| CN86102761A (zh) | 1987-02-25 |
| EP0201735A1 (de) | 1986-11-20 |
| US4774240A (en) | 1988-09-27 |
| AU590267B2 (en) | 1989-11-02 |
| DK187186D0 (da) | 1986-04-23 |
| PT82442A (en) | 1986-05-01 |
| EP0201735B1 (de) | 1990-09-12 |
| FI82036C (sv) | 1991-01-10 |
| ES554285A0 (es) | 1988-05-16 |
| IL78557A0 (en) | 1986-08-31 |
| AU5672686A (en) | 1986-10-30 |
| PT82442B (pt) | 1988-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI82036B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara n-indolyletylsulfonsyraamider. | |
| KR950007753B1 (ko) | 신규 인돌 유도체, 그 제조방법 및 그를 함유하는 의약 조성물 | |
| KR940007302B1 (ko) | 시클로알카노 [1,2-b]인돌-술폰아미드 및 그의 제조 방법 | |
| US7645784B2 (en) | Benzimidazole derivatives | |
| OA12938A (en) | Indole derivatives as beta-2 agonists. | |
| PT86425B (pt) | Processo para a preparacao de 2-aminotetralinas 8-substituidas | |
| LV11028B (en) | Novel benzimidazole and azabenzimidazole derivatives | |
| JPH06279404A (ja) | 新規ニトロインドール誘導体 | |
| PT88044B (pt) | Processo para a preparacao de acidos tetra-hidrocarbazole-1-alcanoicos | |
| NO172389B (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazoler | |
| JP2002533439A (ja) | グルカゴン拮抗剤または逆作用剤 | |
| PT2234968E (pt) | Derivado (aza)indolo substituído na posição 5, composição farmacêutica que o compreende, compostos intermediários e seu processo de preparação | |
| ZA200006714B (en) | Novel heterocyclically substituted amides with cysteine protease-inhibiting effect. | |
| JPH0278660A (ja) | テトラヒドロ―１―ベンズ―［ｃ，ｄ］‐インドールプロピオン酸スルフオンアミド類 | |
| JP2000178243A (ja) | ビフェニルアミジン誘導体 | |
| CA2006115A1 (en) | Capsaicin derivatives | |
| PL205193B1 (pl) | Sposób wytwarzania 1-(9'H-karbazol -4'-iloksy)-3-(2''-(2'''-metoksyfenoksy)etyloamino)-2-propanolu | |
| PT95728A (pt) | Processo para a preparacao de cicloalcano{b}hidroindole sulfonamidas e cicloalcano{b}indole-sulfonamidas substituidas | |
| US3501465A (en) | 3-indolyl lower aliphatic amines | |
| CA2416220C (en) | Preparation of phosphatase inhibitors | |
| JPH0753708B2 (ja) | 新規ｎ−ベンジル−ｎ１−フェニル−および−フェナルキル−チオ尿素類 | |
| ES2225108T3 (es) | Inhibidores de la enzima tace de acido hidroxamico arilsulfonamidico acetilenico y de amida de acido fosfinico. | |
| CA2613742A1 (en) | Novel derivatives of amino acids for treatment of obesity and related disorders | |
| MX2007014224A (es) | Estirilsulfonamidas, su obtencion y uso como agentes farmaceuticos. | |
| US9988389B2 (en) | Processes for making ponatinib and intermediates thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed | ||
| MM | Patent lapsed |
Owner name: BAYER AKTIENGESELLSCHAFT |